BRIEF-Royalty bid backed by 7.5 pct of Elan shareholders pre-extension

DUBLIN, June 7 Fri Jun 7, 2013 2:17am EDT

DUBLIN, June 7 (Reuters) - Royalty Pharma Us Partners LP : * Royalty Pharma says as of June 6, had received valid acceptance of 7.5 percent of maximum Elan shares affected * Royalty Pharma says valid acceptances received before it announced extension of closing date for Elan bid

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.